Sorry, you need to enable JavaScript to visit this website.
    Medicines

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature

New York, NY, April 26, 2019 – Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling one lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, to the consumer level. Pfizer Consumer Healthcare initiated this recall due to the potential that a HeatWrap could include cells that have a higher cell temperature than specified.

The use of a wrap with a cell with increased temperature poses a potential risk of skin injuries such as burns/blisters and/or skin irritation on the wrap applied area. The product label recommends the user to stop use or wear a layer of clothing if the product feels too hot to prevent skin injuries.

ThermaCare® Back Pain Therapy HeatWraps provide heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, strains, sprains, and arthritis.

The ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, master lot impacted is S97473, UPC 305733010037 (Lower Back and Hip Therapy, 2 count carton) and was used in the manufacturing of 17 retail display case sub lots.

ThermaCare® HeatWraps Retail Display Information

Carton/Pouch Master Lot NumberRetail Display Lot NumberRetail Display SKURetail Display UPC
S974737216LBF00573171336305731713367
S974737216LAF00573171336305731713367
S974737199JBF00573171373305731713732
S974737199JAF00573171373305731713732
S974737195EAF00573301003N305731713732
S974737195EBF00573301003N305731713732
S974737188NBF00573171516305731715163
S974737188NAF00573171516305731715163
S974737207SAF00573171403305731714036
S974737207SBF00573171403305731714036
S974737206SAF00573171403305731714036
S974737205SAF00573171403305731714036
S974737201SBF00573171403305731714036
S974737202SAF00573171403305731714036
S974737200SBF00573171403305731714036
S974737201SAF00573171403305731714036
S974737200SAF00573171403305731714036

This master lot and display case sub lots were distributed nationwide to retailers, wholesalers and distributors in the United States and Puerto Rico from June 2017 through March 2018.

Pfizer Inc. places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process.

Pfizer Consumer Healthcare is notifying consumers of this recall with this public notification. Wholesalers, distributors and retailers with an existing inventory of the lot being recalled should stop use and distribution and quarantine the product immediately. Wholesalers, distributors and retailers who have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. For retailer instructions on returning product or additional assistance, call Stericycle at 1- 800-805-3093 between the hours of 8 a.m. to 5 p.m. ET, Monday through Friday.

Pfizer Consumer Healthcare is removing the product in question from store shelves and asking consumers who have purchased and are still in possession of the affected product to discontinue use of the product, record the lot number, throw the product away in its entirety without opening the foil pouch, and to please contact the Pfizer Consumer Healthcare Information Line at 1-800- 323-3383 (Mon-Fri, 9am-5pm EST) for replacement or reimbursement. Note: The lot number can be found on the side of ThermaCare cartons and on the back of ThermaCare pouches.

If consumers have questions regarding this recall or to report an adverse event or product complaint, contact the Pfizer Consumer Healthcare Information Line at 1-800-323-3383 (Mon-Fri, 9am-5pm EST).

Consumers should contact their healthcare provider if they have experienced any problems that may be related to using this product.

Adverse reactions or quality problems experienced with the use of this product may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being executed with the knowledge of the U.S. Food and Drug Administration.

# # # # #

Media Contact:
Kim Bencker
610-329-1340

Sign up for the latest Pfizer Wire news alerts

Receive real-time updates on Pfizer’s news delivered directly to your inbox.

Our Pipeline: Potential Breakthroughs in the Making

We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

Coronavirus Resources

Learn about SARS-CoV-2, the coronavirus that causes COVID-19, what you can do to stay safe and prevent the spread, and our scientific efforts to help bring an end to the current global health crisis.

Making the COVID-19 Oral Treatment

How 2,000+ Pfizer team members made it happen.

Product Hub

Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and 30+ clinical trials, all before its first prescription.

Paxlovid Manufacturing B-roll Video

Supplemental video of manufacturing Paxlovid.

Stay up to date on the latest news and alerts through the Pfizer Wire

Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

 

Sign Up Now